Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response
Lilly to build $6bn Alabama facility
PsiThera unveiled with $47.5m funding to advance oral medicines
Rapid diagnostic breakthrough against Klebsiella
Pan Cancer T raises €10m for first-in-human trial of novel TCR-T cell therapy for triple-negative breast cancer
Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma